A Digimed Oncology PharmacoTherapy Registry

Patients will be prescribed the DMP and DigiMedsâ„¢ (capecitabine or supportive medications) by their healthcare provider. The pharmacy will co-encapsulate the prescribed medication with a sensor.

The actual doses of DigiMedsâ„¢ will be based on standard of care as prescribed by treating physician. Patients will be instructed in the use of the DigiMedsâ„¢ and the DMP based on standard of care plus use of the DMP system.

Every effort should be made to take the DigiMedsâ„¢ as prescribed.

Patients in this study will be given the option to use their personal smartphone or will be provided a provisioned iPad to use for the duration of the study. Each patient will receive a Starter Kit comprised of two wearable sensor pods, adhesive strips, and instructions. Additionally, some kits may contain the provisional iPad Mini and charger for those without an approved smart device. Should a device malfunction occur, such as a broken pod, the patient can replace it with their spare pod. Broken pods should be returned to Proteus as soon as possible and all pods must be returned to the clinic upon completion of the study.